Breast Cancer in Maharat Nakhon Ratchasima Hospital
Article Sidebar
Main Article Content
Abstract
Background: Breast cancer is the second common cancer among Thai women. The delay in diagnosis and treatment of breast cancer leads to the progression of the disease to late stage and is associated with high mortality rate. Objective: To describe the characteristic, tumor size, tumor stage, treatment and complications of the breast cancer. Patients & Methods: Retrospective descriptive study from medical record was performed in breast cancer patients who underwent treatment at Maharat Nakhon Ratchasima Hospital, between January 1-December 31, 2007. Results: There were 173 patients, mean age was is 54.2±9.4 years old, the most common presentation was breast mass 92%. The majority of them presented at stage II and III. Pathology was invasive ductal carcinoma 91.7%. The most frequent operation was modified radical mastectomy (MRM) 89.2%. The complications were found in 23.4% of operated patients whereas the most prevalent was seroma. The average of duration of hospital stay was 9.9±3.9 days (range 3-74 days). Conclusion: Breast cancer in Maharat Nakhon Ratchasima, most frequently presented at stage II-III. Mean age was 54.2 years old. Most common presentation was painless breast mass and the most frequently treatment in the majority was MRM. Most common complication after surgery was seroma.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Chaiwerawatana A. Breast cancer in Thailand: Vol IV. [cited 2008 Apr 30].Available from: URL:http://www.nci.go.th/File_download/Cancer%20In%20Thailand%20IV/C-II-13.PDF
Morabia A, Wynder EL. Epidemiology and natural history of breast cancer. Implications for the body weight breast cancer controversy. Surg Clin North Am 1990; 70: 739-52.
ธรรมนิตย์ อังศุสิงห์. Screening mammography: when for Thai women? ใน: ศุภกร โรจนนินทร์, อดุลย์ รัตนวิจิตราศิลป์, กริช โพธิสุวรรณ, วารินทร์ ตัณฑ์ศุภศิริ, บรรณาธิการ. Head, neck and breast surgery 2.กรุงเทพมหานคร: เรือนแก้ว; 2543. หน้า 306-24.
Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-32.
Elwood JM, Moorehead WP. Delay in diagnosis and long term survival in breast cancer. Br Med J 1980; 280: 1291-4.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005; 365: 1687-717.
Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, et al; ATAC Trialists’ Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: first results of the ATAC randomized trial. Lancet 2002; 359: 2131-9.
Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, et al. A comparison of letrozole and tamoxifen in postmenopausal woman with early breast cancer. N Engl J Med 2005; 353: 2747-57.
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673-84.
Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2 positive breast cancer. N Engl J Med 2005; 353: 1659-72.
Fisher B, Anderson S, Bryant J, Margo lese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
Benson EA. Symptom and signs of operable breast cancer 1997-1981. Br J Surg 1983; 70: 350-3.
Thongsuksai P, Chongsuvivatwong V, Sriplung H. Delay in breast cancer care: a study in Thai women. Med Care 2000; 38: 108-14.
Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275: 913-8.
อดุลย์ รัตนวิจิตราศิลป์. Management of DCIS; nonpalpable and clinically palpable. ใน: ศุภกร โรจนนินทร์, อดุลย์ รัตนวิจิตราศิลป์, กริช โพธิสุวรรณ, วารินทร์ ตัณฑ์ศุภศิริ, บรรณาธิการ. Head, neck and breast surgery 2. กรุงเทพมหานคร: เรือนแก้ว; 2543. หน้า 345-52.
Fan J, Wang L, Wang XJ, Wu J, Lu JS, Di GH, et al. Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol 2006; 132: 573-8.